News

Amundi Launches New Tranche of Gold-Backed ETC Securities

Amundi Launches New Tranche of Gold-Backed ETC Securities

Introduction to Amundi's Latest Gold ETC Issuance

Amundi Physical Metals plc has recently announced the issuance of a fresh batch of exchange-traded commodities (ETCs) under the Amundi Physical Gold ETC. This series offers investors an opportunity to benefit from the fluctuations in gold prices, making it an attractive investment option for those looking to diversify their portfolios.

Details of the New Gold ETC Tranche

The latest tranche, identified as number 639, comprises 28,000 new ETC Securities. This is part of a well-established pattern under the Secured Precious Metal Linked ETC Securities Programme, which is specifically designed to provide a secure investment in precious metals.

Structure and Benefits of the ETC Securities

Investors can take advantage of these ETC Securities, which are structured to provide direct exposure to gold prices without having to physically possess the metal. Each security is backed by a quantifiable amount of gold, with the initial allocation set at 0.04 fine troy ounces. With this new issue, the total number of ETC Securities within this series will reach 52,803,759.

Trading and Listing Information

The newly issued ETC Securities are set to be listed on numerous European exchanges, including Euronext Paris, Euronext Amsterdam, Deutsche Börse, and Borsa Italiana. Additionally, they will be available for trading on the main market of the London Stock Exchange and the International Quotation System in the Mexican Stock Exchange.

Understanding the Expense Ratio

For potential investors, it is important to note that these ETC Securities come with an Expense Ratio of 0.12% per annum. This fee will contribute to covering the issuer's operational costs. Each ETC Security has a nominal amount set at USD 5.085, alongside a specified interest amount of USD 0.051 that is expected to benefit the holders of these securities.

Company Overview

Amundi Physical Metals plc operates as a public company established in Ireland, focusing on the issuance of ETC Securities linked to gold prices. It serves as a special purpose vehicle that enhances access to gold investments, providing a flexible trading option for investors.

Security Measures and Repayment Terms

This recent issuance is structured with a maturity date scheduled for May 23, 2118. The securities themselves are secured by the gold owned by Amundi. However, it is crucial for investors to understand that in cases of early or final redemption, there are limited recourse provisions in place. This means that in certain scenarios, the full repayment might not be guaranteed if the liquidation of the gold does not yield sufficient funds.

Conclusion

The launch of this latest tranche signifies Amundi's ongoing commitment to providing investors with convenient access to gold as an asset class. As the demand for precious metals remains strong among investors seeking hedge against inflation and market volatility, these ETC Securities stand out as a viable option for many.

Frequently Asked Questions

What is the purpose of the Amundi Physical Gold ETC?

The Amundi Physical Gold ETC offers investors exposure to the price of gold without requiring them to hold physical gold.

How many ETC Securities were issued in this tranche?

In this tranche, a total of 28,000 ETC Securities were issued.

What is the expense ratio for the ETC Securities?

The expense ratio for these ETC Securities is set at 0.12% per annum.

Where will the new ETC Securities be listed?

The new ETC Securities will be listed on several exchanges, including Euronext, Deutsche Börse, and the London Stock Exchange.

What does limited recourse mean for investors?

Limited recourse means that in some situations, investors may not receive full repayment upon redemption, depending on the liquidation proceeds of the metal.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 34

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 38

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 51

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 29

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 39

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 21

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 26

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering States to Value Workforce Credentials Effectively

Updated Category News Views 207

Initiating FutureReady States for Workforce Empowerment The FutureReady States initiative, spearheaded by the Lumina Foundation, is a transformative approach to evaluating workforce credential effectiveness. This program is designed to help states understand and enhance their investment in workforce training policies that yield significant economic benefits for both...

Continue Reading
Revolutionizing ADC Characterization with Biozen Native Columns

Updated Category News Views 467

Transforming Biotherapeutic Characterization First of its Kind in Biotherapeutic Antibody Characterization Phenomenex Inc., a leader in separation science technology, has launched Biozen Native RP-1 and RP-5 chromatography columns. These innovative products are engineered to meet the growing demand for effective characterization methods for Antibody-Drug Conjugates...

Continue Reading
Liberty HealthShare: A Compassionate Approach to Healthcare

Updated Category News Views 150

Liberty HealthShare: A Shift in Healthcare Sharing In recent years, many individuals have faced significant concerns about healthcare costs and insurance availability. Liberty HealthShare is stepping up to provide a compassionate alternative for those seeking an effective solution to diminishing healthcare options, especially amid rising premiums and decreasing coverage....

Continue Reading
SelectQuote, Inc. Announces Impressive Q2 Fiscal Results

Updated Category News Views 114

Record Quarter for SelectQuote, Inc. SelectQuote, Inc. (NYSE: SLQT) reported significant growth in its consolidated revenue for the second quarter of fiscal year 2025, reaching $481.1 million. This reflects a notable increase from $405.4 million in the same quarter of the prior year. Alongside revenue growth, the company achieved consolidated net income of $53.2 million,...

Continue Reading
Parker Hannifin to Reveal Fiscal 2025 Q2 Earnings Insights

Updated Category News Views 203

Parker Hannifin Corporation Upcoming Earnings Announcement Parker Hannifin Corporation (NYSE: PH), recognized as a global leader in motion and control technologies, has announced its plans to release its fiscal 2025 second quarter earnings. This exciting update is set to take place before the stock market opens on January 30, 2025. Investors and analysts eagerly...

Continue Reading